# A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects

> **NCT03430661** · PHASE1 · COMPLETED · sponsor: **Viatris Innovation GmbH** · enrollment: 77 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ACT-246475
- **DRUG:** Clopidogrel
- **DRUG:** Prasugrel
- **DRUG:** Placebo
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT03430661
- **Lead sponsor:** Viatris Innovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-29
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430661, "A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03430661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*